Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.
2.

Inhibition of FAK prevents blister formation in the neonatal mouse model of pemphigus vulgaris.

Gil MP, Modol T, España A, López-Zabalza MJ.

Exp Dermatol. 2012 Apr;21(4):254-9. doi: 10.1111/j.1600-0625.2012.01441.x. Epub 2012 Feb 10.

PMID:
22320676
3.

The role of nitric oxide synthases in pemphigus vulgaris in a mouse model.

Marquina M, España A, Fernández-Galar M, López-Zabalza MJ.

Br J Dermatol. 2008 Jul;159(1):68-76. doi: 10.1111/j.1365-2133.2008.08582.x. Epub 2008 Jul 1.

PMID:
18476963
4.

An imbalance in Akt/mTOR is involved in the apoptotic and acantholytic processes in a mouse model of pemphigus vulgaris.

Pretel M, España A, Marquina M, Pelacho B, López-Picazo JM, López-Zabalza MJ.

Exp Dermatol. 2009 Sep;18(9):771-80. doi: 10.1111/j.1600-0625.2009.00893.x. Epub 2009 Jun 23.

PMID:
19552768
5.

Apoptotic mechanism in pemphigus autoimmunoglobulins-induced acantholysis--possible involvement of the EGF receptor.

Frusić-Zlotkin M, Raichenberg D, Wang X, David M, Michel B, Milner Y.

Autoimmunity. 2006 Nov;39(7):563-75.

PMID:
17101500
6.

Differential coupling of M1 muscarinic and alpha7 nicotinic receptors to inhibition of pemphigus acantholysis.

Chernyavsky AI, Arredondo J, Piser T, Karlsson E, Grando SA.

J Biol Chem. 2008 Feb 8;283(6):3401-8. Epub 2007 Dec 11.

7.

Apoptosis is not required for acantholysis in pemphigus vulgaris.

Schmidt E, Gutberlet J, Siegmund D, Berg D, Wajant H, Waschke J.

Am J Physiol Cell Physiol. 2009 Jan;296(1):C162-72. doi: 10.1152/ajpcell.00161.2008. Epub 2008 Nov 5.

9.

Desmoglein versus non-desmoglein signaling in pemphigus acantholysis: characterization of novel signaling pathways downstream of pemphigus vulgaris antigens.

Chernyavsky AI, Arredondo J, Kitajima Y, Sato-Nagai M, Grando SA.

J Biol Chem. 2007 May 4;282(18):13804-12. Epub 2007 Mar 7.

10.

Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions.

Nguyen VT, Ndoye A, Shultz LD, Pittelkow MR, Grando SA.

J Clin Invest. 2000 Dec;106(12):1467-79.

11.

Biphasic activation of p38MAPK suggests that apoptosis is a downstream event in pemphigus acantholysis.

Lee HE, Berkowitz P, Jolly PS, Diaz LA, Chua MP, Rubenstein DS.

J Biol Chem. 2009 May 1;284(18):12524-32. doi: 10.1074/jbc.M808204200. Epub 2009 Mar 7.

12.

Intraperitoneal injection of pemphigus vulgaris-IgG into mouse depletes epidermal keratinocytes of desmoglein 3 associated with generation of acantholysis.

Shu E, Yamamoto Y, Aoyama Y, Kitajima Y.

Arch Dermatol Res. 2007 Jun;299(3):165-7. Epub 2007 Apr 13.

PMID:
17431647
13.

In vivo blockade of pemphigus vulgaris acantholysis by inhibition of intracellular signal transduction cascades.

Sánchez-Carpintero I, España A, Pelacho B, López Moratalla N, Rubenstein DS, Diaz LA, López-Zabalza MJ.

Br J Dermatol. 2004 Sep;151(3):565-70.

PMID:
15377341
14.

Pemphigus vulgaris: recent advances in our understanding of its pathogenesis.

Femiano F.

Minerva Stomatol. 2007 Apr;56(4):215-23. Review. English, Italian.

15.

Apoptolysis: a novel mechanism of skin blistering in pemphigus vulgaris linking the apoptotic pathways to basal cell shrinkage and suprabasal acantholysis.

Grando SA, Bystryn JC, Chernyavsky AI, Frusić-Zlotkin M, Gniadecki R, Lotti R, Milner Y, Pittelkow MR, Pincelli C.

Exp Dermatol. 2009 Sep;18(9):764-70. doi: 10.1111/j.1600-0625.2009.00934.x. Epub 2009 Jun 25.

PMID:
19555352
16.

Pemphigus vulgaris IgG cause loss of desmoglein-mediated adhesion and keratinocyte dissociation independent of epidermal growth factor receptor.

Heupel WM, Engerer P, Schmidt E, Waschke J.

Am J Pathol. 2009 Feb;174(2):475-85. doi: 10.2353/ajpath.2009.080392. Epub 2009 Jan 15.

18.

Pemphigus vulgaris autoimmune globulin induces Src-dependent tyrosine-phosphorylation of plakophilin 3 and its detachment from desmoglein 3.

Cirillo N, AlShwaimi E, McCullough M, Prime SS.

Autoimmunity. 2014 Mar;47(2):134-40. doi: 10.3109/08916934.2013.866100. Epub 2013 Dec 16.

PMID:
24328683
20.

Preclinical studies identify non-apoptotic low-level caspase-3 as therapeutic target in pemphigus vulgaris.

Luyet C, Schulze K, Sayar BS, Howald D, Müller EJ, Galichet A.

PLoS One. 2015 Mar 6;10(3):e0119809. doi: 10.1371/journal.pone.0119809. eCollection 2015.

Supplemental Content

Support Center